Richards Timothy T. 4

What Happened Timothy T. Richards, a director of ClearPoint Neuro, received an award of 222 shares on 2026-07-01. The shares were issued at $17.84 per share for a total value of $3,960. This transaction is coded as an acquisition/award (A) — shares issued as compensation rather than an open-market purchase.

Key Details

• Transaction date and price: 2026-07-01 at $17.84 per share (total $3,960).
• Filing date: Form 4 filed 2026-07-06 (appears to be filed late; Form 4s are generally due within 2 business days of the transaction).
• Shares owned after transaction: Not reported in the provided filing excerpt.
• Footnote: Shares were issued under the issuer’s Seventh Amended and Restated 2013 Incentive Compensation Plan to satisfy fees owed under the Non-Employee Director Compensation Plan; issuance price was the closing price on June 30, 2026.

Context

• This was an award of shares as director compensation (routine non-employee director pay), not a purchase or sale on the open market. Such awards are common and reflect compensation, not necessarily a signal about the director’s view of the stock.
• No option exercise, sale, gift, or 10% owner activity is involved in this transaction.